Icon

VEMLIDY (nda208464)- (EQ 25MG BASE)

TENOFOVIR ALAFENAMIDE FUMARATE GILEAD SCIENCES INC
EQ 25MG BASE
Yes No
2033-Feb-15 2020-Nov-05
None 2019-Nov-11
None No
VEMLIDY is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 12 years of age and older with compensated liver disease.
2 4 0
Total Other Developers 16
Drugs with Suitability No
EQ 25MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.